Trial Profile
The effect of Lixisenatide on triacylglycerol and glucose metabolism in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 11 Sep 2018 Results published in the Journal of Clinical Endocrinology and Metabolism
- 13 Jun 2017 Results of effects of lixisenatide on postprandial lipoprotein kinetics (n=8) presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 13 Jun 2017 Results assessing action of lixisenatide on mixed meal disposition presented at the 77th Annual Scientific Sessions of the American Diabetes Association